Treatment patterns in acute myocardial infarction patients initiated with prasugrel or clopidogrel during the index hospitalisation with one year follow-up (H7T-FR-B016)

Study identification

• EU PAS number:
  EUPAS5972
• Study ID:
  20451
• Official title and acronym:
  Treatment patterns in acute myocardial infarction patients initiated with prasugrel or clopidogrel during the index hospitalisation with one year follow-up (H7T-FR-B016)
• DARWIN EU® study:
  No
• Study countries:
  France
• Study description:
  This study is a retrospective, nonintervention cohort study whose main objective is to provide information on the routine use of prasugrel and clopidogrel (as a reference) in France during the index hospitalization and during one-year follow-up in patients hospitalized with acute Myocardial Infarction (MI).
• Study status:
  Finalised

Research institutions and networks

Institutions

FAST MI

Study timelines

Date when funding contract was signed

Planned: 01/10/2010

Actual: 01/10/2010

Study start date

Planned: 01/10/2010

Actual: 01/10/2010

Date of final study report

Planned: 15/10/2013

Actual: 15/10/2013

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Eli Lilly and Company and Daiichi Sankyo, Inc.

Regulatory

• Was the study required by a regulatory body?:
  Yes
• Is the study required by a Risk Management Plan (RMP)?:
  EU RMP category 3 (required)